Business
atai Life Sciences to Participate in Upcoming November Investor Conferences
NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform
About this update from Ataibeckley Inc.
[{"type":"text","content":"NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that it will participate in the following upcoming investor conferences in November: Presentation details can be found below: Berenberg US CEO Conference 2021Format: 1x1 MeetingsDates: Tuesday, November 9th, 2021 – Wednesday, November 10th, 2021 Credit Suisse 30th Annual Healthcare ConferenceFormat: Fireside ChatDate and Time: Thursday, November 11th, 2021, 9:40 a.m. ETWebcast Link: https://kvgo.com/cs-2021-healthcare-conf/atai-life-sciences-nov 12th Annual Jefferies London Healthcare ConferenceFormat: Fireside ChatDate and Time: Thursday, November 18th, 2021, 8:00 a.m. ETWebcast Link: https://wsw.com/webcast/jeff201/atai/1818738 The presentations and archived webcasts will also be accessible in the Events section of atai’s website. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to acquiring, incubating and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. atai's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapy and other drugs with differentiated safety profiles and therapeutic potential. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies, seeking to effectively treat and ultimately heal mental health disorders. atai's mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. atai is headquartered in Berlin, with offices in New York and London. For more information, please visit www.atai.life. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forwar...